What your donations do

Here's an example of what the JDRF does with the money Team Shelby raises. We are a vital part of a much larger global effort.

See more examples in the Research Corner.

August 23, 2004
BOSTON-The Juvenile Diabetes Research Foundation (JDRF) and Harvard Medical School today announced the opening of the JDRF Center for Immunological Tolerance in Type 1 Diabetes at Harvard Medical School, Generously Supported by Marshalls Ten Year Partnership with JDRF.

The Center was developed because advances in the immune tolerance area are critical for finding better treatments, and eventually a cure, for type 1 diabetes. The primary goals of the JDRF Center for Immunological Tolerance at Harvard Medical School are:

* understanding how immunological tolerance breaks down to provoke type 1 diabetes
* learning how to re-establish tolerance in order to prevent or cure type 1 diabetes, in particular via islet transplantation
* providing a framework for integrating basic research and clinical endeavors focused on islet transplantation
* serving as a magnet for research on immunological tolerance in type 1 diabetes at Harvard Medical School and its affiliated hospitals, and in the Boston area more generally
* becoming a reservoir for new technologies and resources to service the worldwide community of type 1 diabetes researchers.

The new Center will be supported by JDRF with a three-year grant of approximately $5 million.

"We are excited about tackling the critical and very complicated area of immune tolerance," says Raphael Dolin, M.D., Dean for Academic and Clinical Programs at Harvard Medical School. "The Center's scientists are dedicated to learning more about immune tolerance and are acutely aware of its potential impact on islet transplantation, which is a very promising strategy for treating and potentially curing diabetes. We are honored to be working with JDRF to help find a cure for type 1 diabetes."